Mytelase Trademark Details

Mytelase was registered on Tuesday, May 21, 1957 and is currently owned by Sanofi-Aventis U.S. LLC under the registration number 645656 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 16 years ago on Friday, June 22, 2007, according to the United State Patent & Trademark Office
Word Mark Mytelase
Status Alive Registered 800 — Registered and Renewed

Current Owner

Sanofi-Aventis U.S. LLC of Bridgewater, NJ

View all trademarks for Sanofi-Aventis U.S. LLC
Other Trademarks for Sanofi-Aventis U.S. LLC

Previous Owners

Sanofi Winthrop, Inc. of New York, NY

View all trademarks for Sanofi Winthrop, Inc.
Other Trademarks for Sanofi Winthrop, Inc.

Sterling Drug Inc. of New York, NY

View all trademarks for Sterling Drug Inc.
Other Trademarks for Sterling Drug Inc.
Serial Number 72010937
Registration Number 645656
Status Date Friday, June 22, 2007
Filing Date Friday, June 22, 2007
Registration Date Tuesday, May 21, 1957
Attorney Susan Upton Douglass

Correspondent

Susan Upton Douglass
Fross Zelnick Lehrman & Zissu, P.C.
6th Floor
866 United Nations Plaza
NEW YORK NY 10017

Case File Statements

Goods & Services Choliner Gic Preparation, Primarily for the Treatment of Myasthenia Gravis, Post-Operative Abdominal Distention, and Post-Operative Urinary Retention

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 6 — Active
Status Date Tuesday, March 1, 1983
First Use Anywhere Thursday, June 7, 1956
First Use In Commerce Thursday, June 7, 1956
Primary Code 018

You must be signed in to print.

Once signed in, look for the PDF button.